Legend BiotechCorp Price to Sales Ratio Over Time

LEGN Stock  USD 60.82  1.00  1.67%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Legend BiotechCorp Performance and Legend BiotechCorp Correlation.
To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide.
  
As of the 1st of December 2023, Price to Sales Ratio is likely to grow to 75.78.

Legend BiotechCorp Quarterly Price to Sales Ratio

69.277

Is Legend BiotechCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend BiotechCorp. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend BiotechCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.96)
Revenue Per Share
1.358
Quarterly Revenue Growth
2.509
Return On Assets
(0.18)
Return On Equity
(0.49)
The market value of Legend BiotechCorp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend BiotechCorp's value that differs from its market value or its book value, called intrinsic value, which is Legend BiotechCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend BiotechCorp's market value can be influenced by many factors that don't directly affect Legend BiotechCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend BiotechCorp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend BiotechCorp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend BiotechCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Price to Sales Ratio Analysis

Compare Legend BiotechCorp and related stocks such as United Homes Group, Nobility Homes, and LGI Homes Price to Sales Ratio Over Time
Select Fundamental
20102011201220132014201520162017201820192020202120222023
UHG2.1062.1062.1062.1062.1062.1062.1062.1062.1062.1062.1062.252.031.9842
NOBH1.9671.9671.9671.9672.0312.0312.0312.0312.0311.6011.6011.6012.0332.2332
LGIH2.2692.2692.2692.2690.8050.770.7131.2890.6780.8911.1241.2460.9440.9495
WVVI1.4281.4281.4282.2771.8561.9452.0581.9721.4821.391.1581.3530.8731.1437
STZ2.8832.8832.8833.1323.6684.3234.3235.5373.9724.8084.8084.6614.5574.4826
MNST4.4544.4544.4545.0287.35210.3318.54810.6477.2038.20210.6519.1648.4759.2026

Legend BiotechCorp and related stocks such as United Homes Group, Nobility Homes, and LGI Homes Price to Sales Ratio description

Price to Sales Ratio is figured by comparing Legend BiotechCorp stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Legend BiotechCorp sales, a figure that is much harder to manipulate than other Legend BiotechCorp multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. An alternative calculation method to [PS]; that measures the ratio between a company's [Price] and it's [SPS].

My Equities

My Current Equities and Potential Positions

Legend BiotechCorp
LEGN
Legend BiotechCorp Fama & French Biotechnology
Biotechnology
Fama & French Classification
LocationNew Jersey; U.S.A
ExchangeNASDAQ Exchange
USD 60.82
When determining whether Legend BiotechCorp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Legend BiotechCorp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Legend Biotechcorp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Legend Biotechcorp Stock:
Check out Legend BiotechCorp Performance and Legend BiotechCorp Correlation.
To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide.
Note that the Legend BiotechCorp information on this page should be used as a complementary analysis to other Legend BiotechCorp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Complementary Tools for Legend Stock analysis

When running Legend BiotechCorp's price analysis, check to measure Legend BiotechCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Legend BiotechCorp is operating at the current time. Most of Legend BiotechCorp's value examination focuses on studying past and present price action to predict the probability of Legend BiotechCorp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Legend BiotechCorp's price. Additionally, you may evaluate how the addition of Legend BiotechCorp to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Legend BiotechCorp technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Legend BiotechCorp technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Legend BiotechCorp trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...